Swarajya
Our View
Dashboards
Magazine
Subscribe
Swarajya
Subscribe
Home
Dashboards
Magazine
Swarajya
Politics
Economics
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Subscriber login
Politics
Economics
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
johnson and johnson
Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder
Bhaswati Guha Majumder
Jul 14, 2021 06:42 PM +05:30 IST
US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its Efficacy
Swarajya Staff
Jun 14, 2021 06:46 PM +05:30 IST
Why Pfizer And Moderna CEOs Are Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet
Bhaswati Guha Majumder
May 21, 2021 04:56 PM +05:30 IST
Moderna And Johnson & Johnson May Participate In Yogi Govt's Global Tender To Procure 40 Million Covid Vaccine Doses
Swarajya Staff
May 11, 2021 01:37 PM +05:30 IST
US FDA Recommends Pause On Johnson & Johnson's Single Dose Vaccine Following Blood Clot Cases
Swarajya Staff
Apr 13, 2021 05:24 PM +05:30 IST
All You Need To Know About Johnson & Johnson’s Covid-19 Vaccine Trial In India
Bhaswati Guha Majumder
Apr 10, 2021 05:16 PM +05:30 IST
Big Pharma In Big Mess: A Crisis Of Credibility
Rajeev Srinivasan
Oct 18, 2019 11:25 AM +05:30 IST
Troubles Haven’t Ended For Johnson & Johnson: Baby Shampoo Fails Watchdog’s Quality Tests
Swarajya Staff
Apr 2, 2019 12:09 PM +05:30 IST
When Stocks Get ‘Powdered’: Johnson & Johnson In Damage-Control Mode Amid Panic-Driven $40 Billion Share Sell-Off
Swarajya Staff
Jan 1, 2019 05:59 PM +05:30 IST
Cancer-Causing Asbestos In Johnson & Johnson’s Baby Powder? India Set To Investigate Following Reuters Report
Swarajya Staff
Dec 19, 2018 06:11 PM +05:30 IST
Johnson & Johnson To Pay Compensation For Faulty Implants Following Government Order
Swarajya Staff
Sep 7, 2018 04:49 PM +05:30 IST
Load More